Patents by Inventor Bryan Paul Morgan

Bryan Paul Morgan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-C7 Antibody Or Antibody Fragment
    Publication number: 20220380444
    Abstract: An antibody or antibody fragment that binds to complement protein C7 in isolation or as part of a protein complex and the various uses, for example for the treatment of a disease associated with the dysregulation of complement in a subject.
    Type: Application
    Filed: August 20, 2020
    Publication date: December 1, 2022
    Inventors: Bryan Paul Morgan, Wioleta Milena Zelek
  • Factor H polymorphisms in the diagnosis and therapy of inflammatory diseases such as age-related macular degeneration
    Patent number: 8501427
    Abstract: The invention relates to antibodies, including monoclonal and polyclonal, or fragments thereof, which discriminate between the histidine and tyrosine isoforms of Complement Factor H and to their use in diagnostic methods and therapeutic treatments relating to Complement Factor H mediated diseases.
    Type: Grant
    Filed: January 23, 2008
    Date of Patent: August 6, 2013
    Assignee: University College Cardiff Consultants Limited
    Inventors: Bryan Paul Morgan, Claire Louise Harris, Svellana Hakobyan
  • FACTOR H POLYMORPHISMS IN THE DIAGNOSIS AND THERAPY OF INFLAMMATORY DISEASES SUCH AS AGE-RELATED MACULAR DEGENERATION
    Publication number: 20100009393
    Abstract: The invention relates to antibodies, including monoclonal and polyclonal, or fragments thereof, which discriminate between the histidine and tyrosine isoforms of Complement Factor H and to their use in diagnostic methods and therapeutic treatments relating to Complement Factor H mediated diseases.
    Type: Application
    Filed: January 23, 2008
    Publication date: January 14, 2010
    Inventors: Bryan Paul Morgan, Claire Louisa Harris, Svellana Hakobyan
  • Porcine CD59 nucleic acids and cells containing the same
    Patent number: 7462466
    Abstract: A graftable animal cell or tissue of a donor species for use in medicine expresses, or is capable of being caused to express, increased amounts of endogenous complement regulatory molecules for preventing activation of complement in a recipient species. Such tissue or organs are useful for xenotransplantation. Porcine complement regulatory proteins CD59, DAF have been sequenced. Also disclosed are methods of inducing in an animal cell or tissue resistance protection against complement attack.
    Type: Grant
    Filed: January 20, 2004
    Date of Patent: December 9, 2008
    Assignee: University of Wales College of Medicine
    Inventors: Bryan Paul Morgan, Neil Kevin Rushmere, Stewart James Hinchliffe, Carmen Wilma Van Den Berg
  • Biological material
    Publication number: 20040163140
    Abstract: A graftable animal cell or tissue of a donor species for use in medicine expresses, or is capable of being caused to express, increased amounts of endogenous complement regulatory molecules for preventing activation of complement in a recipient species. Such tissue or organs are useful for xenotransplantation. Porcine complement regulatory proteins CD59, DAF have been sequenced. Also disclosed are methods of inducing in an animal cell or tissue resistance protection against complement attack.
    Type: Application
    Filed: January 20, 2004
    Publication date: August 19, 2004
    Applicant: UNIVERSITY OF WALES COLLEGE OF MEDICINE
    Inventors: Bryan Paul Morgan, Neil Kevin Rushmere, Stewart James Hinchliffe, Carmen Wilma Van Den Berg